Skip to content
AgingResearch.News
  • HomeHome
  • SearchSearch
  • AskAsk
  • FollowingFollowing
  • SavedSaved
Join freeSign inSign inSign in
AgingResearch.NewsJoin free

VPS-34 inhibitor

VPS-34 inhibitor has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jul 11, 2023: “Partial inhibition of class III PI3K VPS-34 ameliorates motor aging and prolongs health span”.

Intervention

1 paper studies itUpdated Jul 11, 2023

  • Model organisms1

Latest

PLOS Biology·Jul 11

Partial inhibition of class III PI3K VPS-34 ameliorates motor aging and prolongs health span

Experiments in wormsInterventions
Paper

Related

  • Lipid and ceramide metabolism1
  • PI3K–AKT signaling1
  • PIK3C31
  • Synapse1
  • Synaptic transmission1
  • vps-341
FooterAI assistantsComparePrivacyTermsContactRSSFollow on X
© 2026 AgingResearch.News
Sidebar

    Join AgingResearch.News

    Free: every story, saved papers, follows in a daily email and 3 questions a day to Ask. 14 days of Plus to start, no card.

    Continue with email

    By continuing, you agree to our Terms and Privacy Policy.

    News

    See allSee all news
    Jonathan, the 194-year-old tortoise, shows stable epigenetic regulation of metabolism and DNA repairResearchGEN +7FAHR-Face AI model captures biological aging and disease-related death risk from photographsResearchThe Lancet Digital Health +2Mouse liver zonation erodes by 18 months alongside rising cellular senescenceResearchFight Aging!

    Trials

    See allSee all trials
    Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and WomenResults posted Oct 13, 2026, Marquette UniversityBenefits of Strength Training in Informal Caregivers of Patients With Alzheimer's DiseaseCompleted Oct 16, 2026, University of SalamancaFisetin for Improving Vascular Function in Older Adults: A Phase II Clinical TrialPhase 2Registered Oct 13, 2026, University of Colorado, Boulder

    Trending

    See allSee all trending stories
    Sleep durationIntervention18 papers in two weeks, usually 1Venous thromboembolismDisease12 papers in two weeks, none in the two months beforeMenopauseDisease43 papers in two weeks, usually 8Metabolic disordersDisease11 papers in two weeks, none in the two months beforePostoperative complicationsDisease14 papers in two weeks, usually 1TelomereCell componentLonger telomeres linked to lower lung disease risk

    Topics

    See allSee all topics
    Mechanisms276Interventions554Biomarkers411Populations642AI & data112Industry & policy16SupplementsPeptidesProtocols
    Footer
    • AI assistants
    • Compare
    • Privacy
    • Terms
    • Contact
    • RSS
    • Follow on X
    • © 2026 AgingResearch.News